Results: 2

1.
Figure 1

Figure 1. From: Novel classes of antibiotics or more of the same?.

The number of new classes of antibiotics which have reached the market, and predictions of novel classes of antibiotics which are needed during the next 100 years.

Anthony RM Coates, et al. Br J Pharmacol. 2011 May;163(1):184-194.
2.
Figure 2

Figure 2. From: Novel classes of antibiotics or more of the same?.

The number of systemic compounds and classes in development and predictions of the number which will reach the market. Based on estimates of drugs in development which are published in the public domain. New classes are in brackets. *Assumptions: percent of compounds which reach the market (CMR International 2009) – 6.25% in Phase I, 25% in Phase II, 50% in Phase III and 75% in Pre-registration. Phase II includes drugs which are in Phase I/II, II ready, II and IIa. Phase III includes drugs in II/III, III ready and III. Market predictions are shown with – which indicates a range of years due to current uncertainty of the length of time – which is required to complete Phase III trials, for example for hospital-acquired pneumonia/ventilator-associated pneumonia.

Anthony RM Coates, et al. Br J Pharmacol. 2011 May;163(1):184-194.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk